A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Phase 4

Completed

• Conditions: Hyperhidrosis
• Interventions: Biological: Botulinum Toxin Type A

• Registration Number: NCT00168480
• Lead Sponsor: Allergan

Brief Summary

This is a three year open-label study in subjects with axillary hyperhidrosis.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-11
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-15
• Primary Completion: 2007-04
• Study Completion: 2007-04
• Status Verified: 2008-09
• Last Update Submitted: 2008-09-26
• Last Update Posted: 2008-09-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 424

Inclusion Criteria

• Marked axillary hyperhidrosis

Exclusion Criteria

• Previous use of botulinum toxin for hyperhidrosis

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Botulinum Toxin Type A	Botulinum Toxin Type A

Primary Outcome Measures

Name	Time	Method
Assessment of axillary sweat production	Every 4 Months

Secondary Outcome Measures

Name	Time	Method
Patient reported health outcome measures	1 Month Post-Treatment Visit